Status
Conditions
Treatments
About
Recent evidence suggests that curcumin supplementation may reduce muscle inflammation, oxidative markers, and muscle damage. The most favourable dosage to elicit these ergogenic effects are yet to be established; both 750mg & 1500mg has been shown to be effective. Curcumin supplementation has been ingested in numerous different ways however, no previous research to date has used curcumin in a hydrolysed (drinkable) format. The aim of this study is to investigate whether hydrolysed curcumin can reduce indices of muscle damage and improve recovery, whilst also examining a potential dose-response effect.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion criteria are as follows:
Exclusion criteria
Exclusion criteria include:
Primary purpose
Allocation
Interventional model
Masking
36 participants in 3 patient groups
Loading...
Central trial contact
Ian Grant, MSc; Luke Hughes, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal